Venture
Earlens Corp
Latest Form D 2025-03-03- CIK 1490171
- State CA
- Other Health Care
- 13 Form D offerings since 2010-05-04
- Total sold
- $287M
- across 13 offerings
- Rounds
- 13
- Form D offerings since 2010-05-04
- Latest round
- $8M
- 2025-03-03 · 021-539594
- Investors
- 6
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2025-03-03 · $8M
- 2010-05-04$4.6M021-141474
- 2011-07-15$500K021-162968
- 2013-01-29$6.2M021-190915
- 2014-02-25$39.8M021-212428
- 2016-06-15$72.1M021-265112
- 2018-05-24$9M021-313186
- 2018-10-25$55.4M021-324337
- 2020-04-08$12.2M021-364560
- 2021-01-07$33.2M021-385540
- 2021-08-27$21.2M021-411540
- 2022-04-25$6M021-443277
- 2024-04-18$18.8M021-510984
- 2025-03-03$8M021-539594
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($72.1M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-539594 | First filed2025-03-03 | Latest2025-03-03 | Sought$10M | Sold$8M | Investors6 | Exemptions506(b) |
| 021-510984 | First filed2024-04-18 | Latest2024-04-18 | Sought$43.6M | Sold$18.8M | Investors8 | Exemptions506(b) |
| 021-443277 | First filed2022-04-25 | Latest2022-04-25 | Sought$30M | Sold$6M | Investors4 | Exemptions506(b) |
| 021-411540 | First filed2021-08-27 | Latest2021-08-27 | Sought$35M | Sold$21.2M | Investors17 | Exemptions506(b) |
| 021-385540 | First filed2021-01-07 | Latest2021-01-07 | Sought$45.1M | Sold$33.2M | Investors91 | Exemptions506(b) |
| 021-364560 | First filed2020-04-08 | Latest2020-04-08 | Sought$20M | Sold$12.2M | Investors8 | Exemptions506(b) |
| 021-324337 | First filed2018-10-25 | Latest2018-10-25 | Sought$70M | Sold$55.4M | Investors147 | Exemptions506(b) |
| 021-313186 | First filed2018-05-24 | Latest2018-05-24 | Sought$20M | Sold$9M | Investors21 | Exemptions506(b) |
| 021-265112 | First filed2016-06-15 | Latest2017-05-25 | Sought$77.3M | Sold$72.1M | Investors59 | Exemptions506(b) |
| 021-212428 | First filed2014-02-25 | Latest2014-04-14 | Sought$39.8M | Sold$39.8M | Investors57 | Exemptions506(b) |
| 021-190915 | First filed2013-01-29 | Latest2013-11-20 | Sought$6.5M | Sold$6.2M | Investors16 | Exemptions506(b) |
| 021-162968 | First filed2011-07-15 | Latest2011-07-15 | Sought$1.5M | Sold$500K | Investors1 | Exemptions506 |
| 021-141474 | First filed2010-05-04 | Latest2010-05-04 | Sought$5M | Sold$4.6M | Investors32 | Exemptions506 |
Who backs Earlens Corp — 5 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2025-03-03
| Name | Relationship |
|---|---|
| William M. Facteau | RelationshipExecutive Officer, Director |
| Jamie Stiles | RelationshipDirector |
| Thomas M. Prescott | RelationshipDirector |
| Kevin Leary | RelationshipDirector |
| David Hardie | RelationshipDirector |
Sales compensation
Named in Item 12 of its Form D filings
| Recipient | CRD | Broker-dealer | Offerings |
|---|---|---|---|
| Carofin, LLC | CRD298717 | Broker-dealer— | Offerings1 |
| Carolina Financial Securities, LLC | CRD41970 | Broker-dealer— | Offerings1 |
Facts
As its latest Form D states them
- Industry
- Other Health Care
- State
- California (CA)
- Exemptions
- Rule 506(b); Rule 506
- First filed
- 2010-05-04
- Latest filing
- 2025-03-03
Who backs Earlens Corp
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗